E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/20/2007 in the Prospect News PIPE Daily.

Memory Pharmaceuticals calls warrants related to October 2006 PIPE

By Sheri Kasprzak

New York, Feb. 20 - Memory Pharmaceuticals Corp. will call warrants issued in its October 2006 private placement.

The warrant holders have until March 5, 2007 to exercise their warrants. After that time, all unexercised warrants will expire.

About 1.1 million warrants remain outstanding. There were 7.1 million warrants issued in the placement.

Based in Montvale, N.J., Memory develops treatments for central nervous system disorders like Alzheimer's disease, schizophrenia and bipolar disorder.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.